Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Redefining quality--implications of recent clinical trials.

× No keyword cloud information.

20 in total

Review 1. What is the future of stroke prevention?: debate: polypill versus personalized risk factor modification.

Authors: Walter N Kernan; Lenore J Launer; Larry B Goldstein
Journal: Stroke Date: 2010-10 Impact factor: 7.914

2. Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.

Authors: Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Yonghee Lee; Soo Jin Kim; Yesl Koh; Eak Kyun Shin
Journal: Int J Cardiol Date: 2008-12-06 Impact factor: 4.164

3. Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature.

Authors: Maria A Potenza; Sara Gagliardi; Leonarda De Benedictis; Addolorata Zigrino; Edy Tiravanti; Giuseppe Colantuono; Antonio Federici; Loredana Lorusso; Vincenzo Benagiano; Michael J Quon; Monica Montagnani
Journal: Am J Physiol Endocrinol Metab Date: 2009-06-16 Impact factor: 4.310

4. Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.

Authors: Gauranga Chandra Dhar
Journal: Can Fam Physician Date: 2009-08 Impact factor: 3.275

5. Endpoint selection and relative (versus absolute) risk reporting in published medication trials.

Authors: Michael Hochman; Danny McCormick
Journal: J Gen Intern Med Date: 2011-08-13 Impact factor: 5.128

6. Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study.

Authors: Zachary A Marcum; Rod Walker; Jennifer F Bobb; Mo-Kyung Sin; Shelly L Gray; James D Bowen; Wayne McCormick; Susan M McCurry; Paul K Crane; Eric B Larson
Journal: J Am Geriatr Soc Date: 2018-10-05 Impact factor: 5.562

Review 7. Hypoglycemia, diabetes, and cardiovascular events.

Authors: Cyrus V Desouza; Geremia B Bolli; Vivian Fonseca
Journal: Diabetes Care Date: 2010-06 Impact factor: 17.152

8. Diminishing efficacy of combination therapy, response-heterogeneity, and treatment intolerance limit the attainability of tight risk factor control in patients with diabetes.

Authors: Justin W Timbie; Rodney A Hayward; Sandeep Vijan
Journal: Health Serv Res Date: 2010-01-08 Impact factor: 3.402

9. Comparing diabetes medications: where do we set the bar?

Authors: Kasia J Lipska; Harlan M Krumholz
Journal: JAMA Intern Med Date: 2014-03 Impact factor: 21.873

Review 10. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.

Authors: Matthias Meier; Michael Hummel
Journal: Vasc Health Risk Manag Date: 2009-11-02